HOUSE_OVERSIGHT_024817.jpg

1000 KB

Extraction Summary

2
People
6
Organizations
1
Locations
1
Events
2
Relationships
2
Quotes

Document Information

Type: Equity research report / financial analysis
File Size: 1000 KB
Summary

This document is the cover page of a Cowen Equity Research report titled 'Cowen's Collective View of CBD,' dated February 25, 2019. The report provides market analysis and projections for the CBD industry, predicting $16 billion in sales by 2025, and highlights specific stocks (WEED, TLRY, TPB). While the content is strictly financial research, the document bears the Bates stamp 'HOUSE_OVERSIGHT_024817,' indicating it was collected as part of a House Oversight Committee investigation.

People (2)

Name Role Context
Vivien Azer Analyst / Researcher
Listed contact for Cowen Research on the report cover.
Michael Cella Recipient / Employee
Named in the watermark text: 'This report is intended for michael.cella@cowen.com'.

Organizations (6)

Name Type Context
Cowen
Financial services firm publishing the report.
Cowen Research
Research division of Cowen.
WEED
Stock ticker symbol (Canopy Growth Corporation) mentioned as 'Outperform rated'.
TLRY
Stock ticker symbol (Tilray) mentioned as 'Outperform rated'.
TPB
Stock ticker symbol (Turning Point Brands) mentioned as 'Outperform rated'.
House Oversight Committee
Implied by the Bates stamp 'HOUSE_OVERSIGHT_024817'.

Timeline (1 events)

February 25, 2019
Publication of Cowen's Collective View of CBD report.
N/A
Cowen Analysts

Locations (1)

Location Context
Mentioned in relation to the proprietary survey and CBD sales projections.

Relationships (2)

Michael Cella Employment/Internal Cowen
Email address michael.cella@cowen.com listed in watermark.
Vivien Azer Employment Cowen
Listed as contact with Cowen email address.

Key Quotes (2)

"We believe U.S. CBD can conservatively generate sales of $16 bn by 2025."
Source
HOUSE_OVERSIGHT_024817.jpg
Quote #1
"Nearly 7% of adults in our proprietary U.S. survey (n = ~2,500) reported using CBD as a supplement, far higher than we expected."
Source
HOUSE_OVERSIGHT_024817.jpg
Quote #2

Full Extracted Text

Complete text extracted from the document (863 characters)

COWEN Equity Research
Cannabis
AHEAD OF THE CURVE® SERIES
COWEN'S COLLECTIVE VIEW OF CBD
FEBRUARY 25, 2019
11 Cowen analysts across consumer, health care, industrials, and regulatory offer a comprehensive view of the global CBD opportunity.
Nearly 7% of adults in our proprietary U.S. survey (n = ~2,500) reported using CBD as a supplement, far higher than we expected.
We believe U.S. CBD can conservatively generate sales of $16 bn by 2025. We offer detailed analysis at the sub-category level, as well as company-specific discussions, including Outperform rated WEED, TLRY, and TPB.
This report is intended for michael.cella@cowen.com. Unauthorized redistribution of this report is prohibited.
Cowen Research
646 562 1330
cowen.research@cowen.com
Vivien Azer
646 562 1351
vivien.azer@cowen.com
CANNABIS
COWENRESEARCH COWEN.COM
HOUSE_OVERSIGHT_024817

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document